Data / Form D filings / Memgen, Inc.
Memgen, Inc.: Form D filings
Memgen, Inc., a biotechnology company in Houston, TX, filed 10 Form D notices with the SEC between 2018 and 2024. The latest, on December 10, 2024, reports $950,002 sold of a $10 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 12 GREENWAY PLAZA, SUITE 1100, Houston, TX, 77046
- Phone
- (832) 548-5651
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1760644
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | New notice | $10,000,000 | $950,002 | $9,049,998 | 2 | Nov 26, 2024 | sec.gov |
| Jun 30, 2023 | Amendment | $10,000,000 | $624,979 | $9,375,021 | 8 | Nov 4, 2022 | sec.gov |
| Nov 17, 2022 | New notice | $5,000,000 | $624,979 | $4,375,021 | 8 | Nov 4, 2022 | sec.gov |
| Dec 14, 2021 | Amendment | $10,000,000 | $9,767,223 | $232,777 | 60 | Nov 30, 2021 | sec.gov |
| Dec 13, 2021 | New notice | $10,000,000 | $9,767,223 | $232,777 | 60 | Nov 30, 2021 | sec.gov |
| Jul 10, 2020 | Amendment | $10,000,000 | $575,000 | $9,425,000 | 7 | May 21, 2020 | sec.gov |
| Jul 10, 2020 | Amendment | $10,000,000 | $575,000 | $9,425,000 | 7 | May 21, 2020 | sec.gov |
| Jun 2, 2020 | New notice | $10,000,000 | $50,000 | $9,950,000 | 1 | May 21, 2020 | sec.gov |
| Sep 23, 2019 | New notice | $5,000,000 | $350,000 | $4,650,000 | 3 | Sep 10, 2019 | sec.gov |
| Dec 4, 2018 | New notice | $1,900,000 | $715,003 | $1,184,997 | 10 | Nov 19, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patricia Bitar | Director | |
| Mark Cantwell | Executive Officer | |
| Christopher Pagano | Director | |
| Robert Coates | Executive Officer, Director | |
| Steven Whitley | Director | |
| Gregory Brown | Executive Officer, Director | |
| Casey Logan | Director | |
| John Poulos | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Dec 9, 2024 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Memgen, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.